Recruiting
COVID-19+1
RecruitingEffectiveness of mCOMBRIAX vaccine compared with high‑dose influenza vaccine and mRNA‑1273 in adults ≥65 years for prevention of influenza and COVID‑19
Registered drugNo placebo
Effectiveness of mCOMBRIAX vaccine compared with high‑dose influenza vaccine and mRNA‑1273 in adults ≥65 years for prevention of influenza and COVID‑19
Registered drugNo placebo
- Disease:COVID-19Influenza
- Substances:SARS-COV-2 JN.1 mRNAINFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED+4
Countries:
Denmark
Denmark- Participants:65+ years · Healthy volunteers
- Substances:SARS-COV-2 JN.1 mRNA

